Vision Point Advisory Group, LLC Charles River Laboratories International, Inc. Transaction History

Vision Point Advisory Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$206.39 - $268.73 $1,857 - $2,418	9 Added 5.96%	160 $33,000
Q1 2024 May 10, 2024	SELL	$203.52 - $273.43 $11,804 - $15,858	-58 Reduced 27.75%	151 $40,000
Q4 2023 Feb 07, 2024	BUY	$164.52 - $238.84 $10,693 - $15,524	65 Added 45.14%	209 $49,000
Q3 2023 Dec 06, 2023	BUY	$194.44 - $217.61 $14,388 - $16,103	74 Added 105.71%	144 $28,000
Q2 2023 Aug 21, 2023	BUY	$183.71 - $210.25 $12,859 - $14,717	70 New	70 $14,000

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Vision Point Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Vision Point Advisory Group, LLC with notifications on news.